These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


238 related items for PubMed ID: 9893141

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?
    Chico A, Pérez A, Córdoba A, Arcelús R, Carreras G, de Leiva A, González-Sastre F, Blanco-Vaca F.
    Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051
    [Abstract] [Full Text] [Related]

  • 3. Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study.
    Soedamah-Muthu SS, Chaturvedi N, Teerlink T, Idzior-Walus B, Fuller JH, Stehouwer CD, Eurodiab ProspectivE Complications Study Group.
    J Intern Med; 2005 Nov; 258(5):450-9. PubMed ID: 16238681
    [Abstract] [Full Text] [Related]

  • 4. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus.
    Wollesen F, Brattström L, Refsum H, Ueland PM, Berglund L, Berne C.
    Kidney Int; 1999 Mar; 55(3):1028-35. PubMed ID: 10027940
    [Abstract] [Full Text] [Related]

  • 5. The relationship among homocysteine, creatinine clearance, and albuminuria in patients with type 2 diabetes.
    Davies L, Wilmshurst EG, McElduff A, Gunton J, Clifton-Bligh P, Fulcher GR.
    Diabetes Care; 2001 Oct; 24(10):1805-9. PubMed ID: 11574446
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Albuminuria and glycemic control. The significance for mortality in non-insulin-dependent diabetes mellitus].
    Gall MA, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving HH.
    Ugeskr Laeger; 1996 Nov 25; 158(48):6907-11. PubMed ID: 8984753
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serum homocysteine levels are associated with the development of (micro)albuminuria: the Hoorn study.
    Jager A, Kostense PJ, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Donker AJ, Stehouwer CD.
    Arterioscler Thromb Vasc Biol; 2001 Jan 25; 21(1):74-81. PubMed ID: 11145936
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Fasting and post-methionine load homocyst(e)ine values are correlated with microalbuminuria and could contribute to worsening vascular damage in non-insulin-dependent diabetes mellitus patients.
    Lanfredini M, Fiorina P, Peca MG, Veronelli A, Mello A, Astorri E, Dall'Aglio P, Craveri A.
    Metabolism; 1998 Aug 25; 47(8):915-21. PubMed ID: 9711985
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fibrinogen and AER are major independent predictors of 11-year cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study.
    Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Pagano G, Cavallo-Perin P, Casale Monferrato Study.
    Diabetologia; 2005 Mar 25; 48(3):427-34. PubMed ID: 15696295
    [Abstract] [Full Text] [Related]

  • 14. Relationship between homocysteine and mortality in chronic kidney disease.
    Menon V, Sarnak MJ, Greene T, Wang X, Pereira AA, Beck GJ, Kusek JW, Selhub J, Collins AJ, Levey AS, Shlipak MG.
    Circulation; 2006 Mar 28; 113(12):1572-7. PubMed ID: 16549639
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes : 5-year follow-up of the Hoorn Study.
    Hoogeveen EK, Kostense PJ, Jakobs C, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD.
    Circulation; 2000 Apr 04; 101(13):1506-11. PubMed ID: 10747342
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetes.
    Krzyzanowska K, Mittermayer F, Krugluger W, Schnack C, Hofer M, Wolzt M, Schernthaner G.
    Atherosclerosis; 2006 Nov 04; 189(1):236-40. PubMed ID: 16414052
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.